Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity

Eitemau Tebyg

• Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
  gan: Corbin, Amie S., et al.
  Cyhoeddwyd: (2010)
• Absence of SKP2 expression attenuates BCR-ABL–induced myeloproliferative disease
  gan: Agarwal, Anupriya, et al.
  Cyhoeddwyd: (2008)
• BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib
  gan: Sherbenou, Daniel W., et al.
  Cyhoeddwyd: (2010)
• Mutant BCR-ABL clones in chronic myeloid leukemia
  gan: Mathisen, Michael S., et al.
  Cyhoeddwyd: (2011)
• A BCR-ABL mutant lacking direct binding sites for the GRB2, CBL and CRKL adapter proteins fails to induce leukemia in mice.
  gan: Kara J Johnson, et al.
  Cyhoeddwyd: (2009-10-01)